Technology
Health
Biotechnology

Innovate Biopharmaceuticals

$1.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.10 (8.00%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell INNT and other stocks, options, ETFs, and crypto commission-free!

About

Innovate Biopharmaceuticals, Inc. Common Stock, also called Innovate Biopharmaceuticals, is a clinical-stage biopharmaceutical company. Read More It foucs on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay P. Madan and Kendyle Woodard in 2012 and is headquartered in Raleigh, NC.

Employees
8
Headquarters
Raleigh, North Carolina
Founded
2012
Market Cap
41.94M
Price-Earnings Ratio
Dividend Yield
Average Volume
652.21K
High Today
$1.35
Low Today
$1.23
Open Price
$1.26
Volume
248.96K
52 Week High
$29.09
52 Week Low
$1.23

Collections

Technology
Health
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
2016 IPO
US

News

Yahoo FinanceMay 9

Innovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San Diego

RALEIGH, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (INNT), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory disease, announced that it plans to host an Analyst Event on Monday, May 20, 2019, in San Diego, CA. The event is intended to provide clinical and operational progress updates, including details regarding the company’s Phase 3 celiac disease clinical trial. Event: Innovate Analyst Event Date: Monday,...

972
Yahoo FinanceMay 1

Innovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct Offering

RALEIGH, N.C., May 01, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (INNT) today announced the closing of its previously announced registered direct offering of 4,318,272 shares of common stock at a purchase price of $2.025 per share, for aggregate gross proceeds of approximately $8.7 million. Innovate also issued unregistered warrants to purchase up to 4,318,272 shares of common stock with an exercise price of $2.13 per share. The warrants are exercisable immediately following the issuance an...

1,256
Yahoo FinanceApr 30

Edited Transcript of INNT earnings conference call or presentation 29-Apr-19 12:00pm GMT

Q1 2019 Innovate Biopharmaceuticals Inc Earnings Call SIMI VALLEY May 1, 2019 (Thomson StreetEvents) -- Edited Transcript of Innovate Biopharmaceuticals Inc earnings conference call or presentation Monday, April 29, 2019 at 12:00:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Jennifer K. Zimmons Strategic Growth International, ...

214

Earnings

-$1.38
-$0.93
-$0.48
-$0.03
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 9, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.